Başlık için Tıp Fakültesi / Faculty of Medicine listeleme

Cemiplimab monotherapy as first-line (1L) treatment of patients with brain metastases from advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) >= 50%: EMPOWER-Lung 1 subgroup analysis.

Sezer, Ahmet (2021)

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Sezer, Ahmet; Kilickap, Saadettin; Gumus, Mahmut; Bondarenko, Igor; Ozguroglu, Mustafa; Gogishvili, Miranda; Turk, Haci M.; Cicin, Irfan; Bentsion, Dmitry; Gladkov, Oleg; Clingan, Philip; Sriuranpong, Virote; Rizvi, Naiyer; Gao, Bo; Li, Siyu; Lee, Sue; McGuire, Kristina; Chen, Chieh I; Makharadze, Tamta; Paydas, Semra; Nechaeva, Marina; Seebach, Frank; Weinreich, David M.; Yancopoulos, George D.; Gullo, Giuseppe; Lowy, Israel; Rietschel, Petra (2021)

Background We aimed to examine cemiplimab, a programmed cell death 1 inhibitor, in the first-line treatment of advanced non-small-cell lung cancer with programmed cell death ligand 1 (PD-L1) of at least 50%. Methods In ...

Cemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 >= 50%

Sezer, A.; Gogishvili, M.; Bentsion, D.; Kilickap, S.; Lowczak, A.; Gumus, M.; Gladkow, O.; Clingan, P.; Sriuranpong, V.; Rizvi, N.; Lee, S.; Li, S.; Snodgrass, P.; Navarro, M.; Lowy, I.; Rietschel, P. (2019)

Cemiplimab-Based Treatment in Advanced NSCLC With Liver Metastases: Updated Analysis From EMPOWER-Lung 1 and EMPOWER-Lung 3

Baramidze, A.; Gessner, C.; Gogishvili, M.; Sezer, A.; Makharadze, T.; Kilickap, S.; Gumus, M.; Li, Y.; Li, S.; Salvati, M.; Pouliot, J. -F.; Seebach, F.; Lowy, I.; Gullo, G.; Rietschel, P. (2023)

Central corneal thickness in type II diabetes mellitus: is it related to the severity of diabetic retinopathy?

Toygar, Okan; Sizmaz, Selcuk; Pelit, Aysel; Toygar, Baha; Yabas Kiziloglu, Ozge; Akova, Yonca (2015)

Background/aim: To compare the central corneal thickness (CCT) of type II diabetes mellitus patients with age- and sex-matched healthy subjects and to determine the association of the severity of diabetic retinopathy and ...

Central Nervous System Metastases in Neuroblastoma: Results of Turkish Pediatric Oncology Group Neuroblastoma 2009 (TPOG-NB-2009) Protocol

Cecen, E.; Ince, D.; Sevinir, B.; Cakir, F. B.; Kurucu, N.; Guler, E.; Vural, S.; Koksal, Y.; Oniz, H.; Oguz, A.; Sarialioglu, F.; Olgun, N. (2018)

Central venous occlusion in hemodialysis access: Comparison between percutaneous transluminal angioplasty alone and nitinol or stainless-steel stent placement

Gur, S.; Oguzkurt, L.; Gedikoglu, M. (2019)

Purpose: The purpose of this study was to compare the primary and secondary patency rates occlusion; of percutaneous transluminal angioplasty (PTA) atone with those of metallic stent placement Angioplasty; in patients with ...

Centralization of mammography reporting with mobile trucks: Turkish experience

Gultekin, M.; Ozturk, C.; Karaca, S.; Boztaş, G.; Turan, S.H.; Dundar, S.; Hacikamiloglu, E.; Araz, L.; Murtuza, K.; Keskinkilic, B. (2018)

Screening via mammography is a complex process to be implemented. Objective: To report the initial results and the effectiveness of newly implemented Turkey's population based breast cancer screening program performed for ...

Cephalometric Mandibular Dimensions in Growing Turkish Children: Trends of Change, Sex-Specific Differences, and Comparisons with Published Norms

Pamukcu, Hande; Tuncer, Nilufer Irem; Pelin, Ismail Can; Zengin, Hatice Yagmur (2022)

Objective: The aims of this study were to investigate cephalometric mandibular dimensions in growing Anatolian Turkish children and to identify the periods of rapid growth for boys and girls. Furthermore, the secondary aim ...

Cerebellar Mutism Caused by Primary Varicella Infection in an Immunocompetent Child

Erol, Ilknur; Ozkale, Yasemin; Saygi, Semra; Alehan, Fusun (2014)

Varicella (chickenpox) is a common childhood infection caused by the varicella-zoster virus, which is often self-limiting and usually benign. Although uncommon, neurologic complications of varicella have been documented ...

Cerebral Sinus Venous Thrombosis: Evaluation of Nineteen Patients

Ocal, Ruhsen Oncel; Ayas, Zeynep Ozozen; Boluk, Ayhan (2018)

Objective: Cerebral sinus venous thrombosis (CSVT) is a disease that can be seen in all age groups with various clinical findings and usually a good prognosis. In this study, evaluation of the complaints on admission, the ...

Cerebral Venous Sinus Thrombosis as a Rare Complication of Systemic Lupus Erythematosus: Subgroup Analysis of the VENOST Study

Goksel, Basak Karakurum (2019)

Aim: Systemic lupus erythematosus (SLE) is an unusual risk factor for cerebral venous sinus thrombosis (CVST). As few CVST patients with SLE have been reported, little is known regarding its frequency as an underlying ...